U.S. Next Generation Diabetes Therapy and Drug Delivery Market Estimated to Reach $6,510 million by 2023 – Abbott Laboratories,Echo Therapeutics,F. Hoffmann-La Roche ,GlySens, Medtronic, Sanofi, Novo Nordisk, MannKind Corporation, Dexcom, Senseonics Select
The U.S. next generation diabetes therapy and drug delivery market was valued at $446 million in 2015, and is estimated to reach $6,510 million by 2023, registering a CAGR of 33.0% from 2017 to 2023. Next generation diabetes therapy and drug delivery devices are used to accurately check the blood glucose levels and deliver insulin into the body. Next generation diabetes drug delivery systems such as oral and inhalable insulin help to introduce insulin into the patient’s body without causing pain and also reduces the risk of skin irritation due to frequent use of needles.
The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, demographic, end user, and region. The product type segment includes inhalable insulin, oral insulin, insulin patch, continuous glucose monitoring systems (CGMS), and artificial pancreas. Based on demographic, the market is bifurcated into adult population (>14years) and child population (14years). Based on indication, the market is divided into diabetes I and II. Based on end user, the market is categorized into diagnostics/clinic, ICU, and home healthcare.
Know More|Download Sample Copy at: https://www.premiummarketinsights.com/sample/AMR00013821
Rise in the number of diabetic cases and the benefits of using these advanced devices over conventional products boost the market growth. The well-established healthcare infrastructure and high R&D activities for the advancement in diabetes therapeutic technology are expected to provide opportunities for market growth. However, less variability in products and cost restraints among low and middle-income population are expected to hinder the market growth. Development of affordable products with fewer side effects and presence of undiagnosed diabetic patients in the U.S. are projected to help to open new doors for the growth of the next generation diabetes therapy and drug delivery market.
KEY MARKET BENEFITS
-This report offers a detailed quantitative analysis of the current market trends from 2014 to 2023 to identify the prevailing opportunities.
-The market estimations provided are based on comprehensive analysis of the key developments in the industry.
-The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to product type, demographics, indications, and end user.
-The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Table of Content:
1.1 Scope of Study
2 Key Takeaways
3 U.S. Next Generation Diabetes Therapy and Drug Delivery Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.3 PEST Analysis
4 U.S. Next Generation Diabetes Therapy and Drug Delivery Market- Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 U.S. Next Generation Diabetes Therapy and Drug Delivery Market Analysis- Global
5.1 Global U.S. Next Generation Diabetes Therapy and Drug Delivery Market Overview
5.2 Global U.S. Next Generation Diabetes Therapy and Drug Delivery Market Forecasts and Analysis
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions U.S. Next Generation Diabetes Therapy and Drug Delivery Market
Get Complete Report at:
Name: Sameer Joshi
Email: [email protected]
Organization: Premium Market Insights
About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.